ArticleThoracic cancer2019
Article in Thoracic cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 7 citations in OpenAlex.
- Predicting solitary pulmonary lesions in breast cancer patients usingBMC pulmonary medicine · 2024Article
- Assessment of chemotherapy resistance changes in human colorectal cancer xenografts in rats based on MRI histogram features.Frontiers in oncology · 2024Article
- Preoperative evaluation and indications for pulmonary metastasectomy.Journal of thoracic disease · 2021Review
- A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.Oncology letters · 2021Article
- Mediastinal Metastasis of Breast Cancer Mimicking a Primary Mediastinal Tumor.The American journal of case reports · 2020Article
- High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients.Thoracic cancer · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifferentiating pulmonary metastasis from primary lung cancer can be challenging in patients with breast malignancy. This study aimed to characterize the imaging features of
methodsWe enrolled 52 patients who received curative treatment for breast cancer but later presented with suspected solitary pulmonary lesions (SPLs) and subsequently underwent
resultsSubsolid lesions, ill-defined borders, lung lesions with negative maximum standardized uptake value, and lesions without
conclusionsCT border, FDG uptake, hilar and/or mediastinal lymph node metastasis, and pleural metastasis are potential markers for diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.